Constitutive activation of Stat3α in brain tumors:: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)

被引:154
作者
Schaefer, LK
Ren, ZY
Fuller, GN
Schaefer, TS
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
关键词
brain tumor; receptor tyrosine kinase; endothelial cells; VEGF; angiogenesis;
D O I
10.1038/sj.onc.1205263
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the normally latent family of transcription factors signal/inducers and activators of transcription (Stat) are activated in a number of human tumors and tumor-derived cell lines. In the case of Stat3, it is believed that this activation leads to the induction of survival signals as well as increased proliferation. In this study, we demonstrate that Stat3 is constitutively activated in glioma and medulloblastoma tumors and that the activated protein localizes predominantly to the tumor endothelial cells in the highly vascularized glioma tumors. Our efforts to elucidate potential mechanism(s) for this activated protein have shown that coexpression of Stat3)c and the vascular endothelial growth factor receptor-2 (VEGFR-2) result in ligand-independent activation of Stat3chi tyrosine phosphorylation and subsequent transcriptional activation in non-endothelial cells. We also show that activated Stat3alpha can increase transcription from the vascular endothelial growth factor (VEGF) gene. Taken together, these results suggest that the activated Stat3chi found in brain tumors may be due to the endothelial tyrosine kinase VEGFR-2 and that Stat3chi may play a central role in autocrine VEGF activation.
引用
收藏
页码:2058 / 2065
页数:8
相关论文
共 40 条
[1]  
BATRA SK, 1995, CELL GROWTH DIFFER, V6, P1251
[2]   Stat3 activation is required for cellular transformation by v-src [J].
Bromberg, JF ;
Horvath, CM ;
Besser, D ;
Lathem, WW ;
Darnell, JE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2553-2558
[3]  
Cao XM, 1996, MOL CELL BIOL, V16, P1595
[4]  
Carroll RS, 1999, CANCER-AM CANCER SOC, V86, P1335, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1335::AID-CNCR32>3.0.CO
[5]  
2-Z
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]   STAT activation by epidermal growth factor (EGF) and amphiregulin - Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1 [J].
David, M ;
Wong, L ;
Flavell, R ;
Thompson, SA ;
Wells, A ;
Larner, AC ;
Johnson, GR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) :9185-9188
[8]   AMPLIFIED, OVEREXPRESSED AND REARRANGED EPIDERMAL GROWTH-FACTOR RECEPTOR GENE IN A HUMAN ASTROCYTOMA CELL-LINE [J].
FILMUS, J ;
POLLAK, MN ;
CAIRNCROSS, JG ;
BUICK, RN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (01) :207-215
[9]   Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase [J].
Fleming, RYD ;
Ellis, LM ;
Parikh, NU ;
Liu, WB ;
Staley, CA ;
Gallick, GE .
SURGERY, 1997, 122 (02) :501-507
[10]  
Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267